Antihypertensive drugs

Legal Information BRAND is a registered trademark of BRAND GMBH + CO KG

https://www.inorganicventures.com/coa-sds-search

Brimonidine tartrate is a quinoxaline derivative and adrenergic α-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension.

Brimonidine tartrate is a quinoxaline derivative and adrenergic α-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension.

Brimonidine tartrate is a quinoxaline derivative and adrenergic α-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension.

Brimonidine tartrate is a quinoxaline derivative and adrenergic α-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Bromazine Hydrochloride.

Bromochlorophenol Blue.

Bromodifluoroacetyl chloride

Product Application:Bromodiiodomethane, is a Iodinated trihalomethanes (ITHMs),which can be used for several medicinal or pharmaceutical taste and odor events in drinking water.

Product Application:Bromodiiodomethane, is a Iodinated trihalomethanes (ITHMs),which can be used for several medicinal or pharmaceutical taste and odor events in drinking water.